Óscar Larrosa

A team from the United States has analyzed nearly twenty studies on melatonin use in children between the ages of 0 and 6 in different countries. Although it appears that melatonin can help improve sleep onset in children with neurological conditions such as autism spectrum disorders, the data indicate that in recent years there has been an increase in sales of these products without a clear understanding of their actual effectiveness and potential long-term consequences for typically developing young children. The results are published in JAMA Network Open. 

Taking melatonin supplements to treat insomnia for more than a year is associated with an increased risk of heart failure—including an increase in hospitalisations and mortality—within five years of use, according to a study presented at a conference of the American Heart Association. The study compared a group of 65,000 adults diagnosed with insomnia who had a prescription for melatonin with another group who did not have a prescription for this supplement.